Labatec Pharma, a leading Swiss-based pharmaceutical company, has introduced Eroxon®, an innovative over-the-counter gel-based treatment for erectile dysfunction (ED), marking a significant milestone as the UAE becomes the first Middle Eastern market to offer this solution following regulatory approval.
Eroxon® is an FDA-approved ED topical treatment, and it holds CE certification in Europe and the United Kingdom. Studies have confirmed its effectiveness as a clinically proven treatment for ED, offering a rapid onset and a favorable benefit-risk profile. This classification as an over-the-counter product makes it particularly attractive to individuals with mild to moderate ED.
Labatec Pharma, in partnership with Alphamed, a healthcare brand under Al Khayyat Investments (AKI), is spearheading the distribution and retailing of Eroxon® in the UAE.
Faisal Darwazeh, CEO of Labatec Pharma, notes: “Labatec is proud to provide access to Eroxon® in the UAE. The inclusion of this innovative product in our portfolio illustrates Labatec’s strong commitment to improving men’s health in the region and around the world.”
Innovative ED Treatment
James Barder, CEO of Futura Medical, says: “Globally, Eroxon® is a proven game changer in the treatment of erectile dysfunction. The launch of Eroxon® in the UAE represents an important milestone for men in the Middle East, and Futura is pleased to support its partner Labatec Pharma in launching Eroxon® in the local market.”
Dr. Yasser Farahat, Chairman of the Arab School of Urology and IUCC Scientific Chair, comments: “The advancements seen in medications today can significantly contribute to improving the lives and relationships of individuals affected by erectile dysfunction. Raising awareness of and encouraging important conversations about ED are crucial in order to provide effective solutions.”
Also Read: Saudi Aid Agency and WHO launches Life-Saving Oxygen Station in Yemen
Labatec Pharma made the announcement of Eroxon®’s commercial retail availability in the UAE during the 12th Emirates International Urological Conference in Dubai, highlighting the country’s dedication to men’s health and well-being.
